Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVEL trial of NanO2 for brain protection after large vessel occlusion stroke
ISRCTN55927994Phase 2Recruiting
- Sponsor
- University of Glasgow
- Start
- Jun 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke and Large-Vessel Ischemic Stroke (LVO) comparing NanO2 with Placebo (2 arms). Started Jun 2025; status: recruiting.
02
Drugs
perflenapent
03
Conditions
ischemic strokeLarge-Vessel Ischemic Stroke (LVO)
Beyond the preview
Go deeper on ISRCTN55927994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN55927994.